These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 5824711

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experimentation with an antibiotic: erythromycin stearate].
    Linquette M, Decoulx M.
    Lille Med; 1967 May; 12(4):Suppl:524-8. PubMed ID: 5619706
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Tolerance and efficiency of erythromycin suppositories used in respiratory infections in ambulatory pediatric practice].
    Rodovalho SF.
    Hospital (Rio J); 1968 Jun; 73(6):1947-52. PubMed ID: 5306207
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Mycoplasmic pneumonia and respiratory tract inflammation].
    Kitamoto O.
    Naika; 1971 Jun; 27(6):1225-7. PubMed ID: 5092035
    [No Abstract] [Full Text] [Related]

  • 10. [Erythromycin and josamycin in respiratory tract infections in children. Comparative therapeutic results].
    Behre U, Wolters K, Daschner FD.
    MMW Munch Med Wochenschr; 1980 Jun 20; 122(25):941-2. PubMed ID: 6772944
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clarithromyocin new approaches to the treatment of respiratory tract infection. Seventh Mediterranean Congress of Chemotherapy. Barcelona, Spain, May 1990.
    J Antimicrob Chemother; 1991 Feb 20; 27 Suppl A():1-124. PubMed ID: 1827093
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of a secretolytic agent (bromhexine) on the penetration of erythromycin into bronchial secretions].
    Bergogne-Berezin E, Pierre J, Dournovo P.
    Fortschr Med; 1982 Jun 24; 100(24):1169-71. PubMed ID: 7049878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B, Wilen-Rosenqvist G, Lehtonen L.
    Arzneimittelforschung; 1993 Sep 24; 43(9):1014-7. PubMed ID: 8240450
    [Abstract] [Full Text] [Related]

  • 17. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan.
    Hsueh PR, Shyr JM, Wu JJ.
    Clin Infect Dis; 2005 Mar 15; 40(6):903-5. PubMed ID: 15736030
    [No Abstract] [Full Text] [Related]

  • 18. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan 15; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.